Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
02/05/2014 | CN103562210A Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
02/05/2014 | CN103562208A Tricyclic gyrase inhibitors |
02/05/2014 | CN103562206A 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
02/05/2014 | CN103562205A Inhibitors of influenza viruses replication |
02/05/2014 | CN103562204A Aminopyrazine compounds useful as inhibitors of TRA kinase |
02/05/2014 | CN103562203A Process for the preparation of 1-(2-methyl-4-(2, 3, 4, 5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L- proline-N, N- dimethylamide |
02/05/2014 | CN103562202A BCL-2/BCL-XL inhibitors and therapeutic methods using the same |
02/05/2014 | CN103562201A Substituted benzoazepines as TOLL-like receptor modulators |
02/05/2014 | CN103562200A Novel imidazole derivatives useful for the treatment of arthritis |
02/05/2014 | CN103562199A Tripeptides incorporating deuterium as inhibitors of hepatitis c virus |
02/05/2014 | CN103562198A Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
02/05/2014 | CN103562197A Solid forms of 3-(5-amino-2methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses |
02/05/2014 | CN103562191A Nitrogen-containing saturated heterocyclic compound |
02/05/2014 | CN103562186A Substituted benzoazepines as toll-like receptor modulators |
02/05/2014 | CN103562185A Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
02/05/2014 | CN103562184A Pharmaceutically active disubstituted pyridine derivatives |
02/05/2014 | CN103562183A Benzoic acid salt of otamixaban |
02/05/2014 | CN103562180A New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds |
02/05/2014 | CN103562159A Process of separating chiral isomers of chroman compounds and their derivatives and precursors |
02/05/2014 | CN103561791A Expandable devices coated with a paclitaxel composition |
02/05/2014 | CN103561775A Liposome containing shRNA molecule for thymidylate synthase, and use for same |
02/05/2014 | CN103561773A Theranostic imaging agents and methods of use |
02/05/2014 | CN103561769A Pharmaceutical preparation |
02/05/2014 | CN103561768A Anti-inflammatory composition |
02/05/2014 | CN103561767A Polyphenol composition for preventing or treating atherosclerosis |
02/05/2014 | CN103561756A Composition for preventing and/or ameliorating cancer-related irreversible metabolism disorders |
02/05/2014 | CN103561750A Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer |
02/05/2014 | CN103561749A Vaginal composition based on alkyl polyglucosides |
02/05/2014 | CN103561748A Method for treating asthenopia |
02/05/2014 | CN103561747A Methods of targeted treatment of frontotemporal lobar degeneration |
02/05/2014 | CN103561746A Pharmaceutical compositions comprising sorbitan esters |
02/05/2014 | CN103561745A Medicaments and methods for treating cancer |
02/05/2014 | CN103561744A Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2-6-dione in treatment of immune-related and inflammatory diseases |
02/05/2014 | CN103561743A Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione |
02/05/2014 | CN103561742A Formulation comprising phenylaminopyrimidine derivative as active agent |
02/05/2014 | CN103561741A Substituted N-aryl pyridinones |
02/05/2014 | CN103561740A Combinations of alpha 7 nicotinic acetylcholine receptor activators and mGluR5 antagonists for use in dopamine induced dyskinesia in Parkinson's disease |
02/05/2014 | CN103561739A Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections |
02/05/2014 | CN103561738A Ropinirole-containing adhesive patch and packaging therefor |
02/05/2014 | CN103561737A Ropinirole-containing adhesive skin patch and packaged product thereof |
02/05/2014 | CN103561736A Methods for treating drug-resistant hepatitis C virus infection with a 5,5-fused arylene or heteroarylene hepatitis C virus inhibitor |
02/05/2014 | CN103561735A Medicinal preparation ''RENESSANS'' having an antibacterial, anti-ulcerous and immuno-modulating action |
02/05/2014 | CN103561734A Synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck |
02/05/2014 | CN103561733A Use of vanadium compounds for maintaining normaglycemia in a mammal |
02/05/2014 | CN103561732A Therapeutic compounds |
02/05/2014 | CN103561731A Dry powder inhaler compositions comprising umeclidinium |
02/05/2014 | CN103561730A Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(-3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods |
02/05/2014 | CN103561729A Anxiolytic effect of pterostilbene |
02/05/2014 | CN103561727A Once daily formulation of lacosamide |
02/05/2014 | CN103561725A Vector for pulmonary delivery, inducing agent, and uses |
02/05/2014 | CN103561724A Pharmaceutical composition for administration to nails |
02/05/2014 | CN103561723A Otamixaban formulations with improved stability |
02/05/2014 | CN103561721A Nasal pharmaceutical formulation comprising fluticasone |
02/05/2014 | CN103561720A Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer |
02/05/2014 | CN103561716A Hair growth and hair restoration material |
02/05/2014 | CN103561715A Peptidyl arginine deiminase 1 and/or 3 activator compounds in the epidermis and uses thereof |
02/05/2014 | CN103561592A Methods for improving bone health in infants using prebiotics |
02/05/2014 | CN103561573A Tyrosine phosphatase and uses thereof to modulate the activity of enzymes involved in the pathology of mycobacterium tuberculosis |
02/05/2014 | CN103556226A Cefathiamidine monocrystal |
02/05/2014 | CN103555726A Unmethylated CpG contained DNA sequence (CpG-DNA) and its application |
02/05/2014 | CN103555725A Sdf-i binding nucleic acids |
02/05/2014 | CN103555528A Health-care wine and preparation method thereof |
02/05/2014 | CN103554985A Repeatedly opened/closed molecule release system of dual-switch response control and preparation method and application |
02/05/2014 | CN103554297A Preparation method and application of high-sulfation-degree radix hedysari polysaccharide sulfate |
02/05/2014 | CN103554289A Rhizoma atractylodis sinensis polysaccharide and extraction method and applications thereof in preparing anti-tumor medicaments |
02/05/2014 | CN103554213A 4-oxa-androstane-3-ketone-17beta-amides derivatives, as well as preparation method and medical applications thereof |
02/05/2014 | CN103554210A Sterides 5 alpha-reductase inhibitor, as well as preparation method and medical application thereof |
02/05/2014 | CN103554205A Compounds and methods for modulating expression of gccr |
02/05/2014 | CN103554204A Capecitabine direct-tabletting crystal as well as preparation method thereof and capecitabine direct tablet |
02/05/2014 | CN103554188A 6-(azacyclo-substitute) anthraquinone platinous chloride complex as well as preparation method and application thereof |
02/05/2014 | CN103554187A Platinum complexes, protein complexes prepared from same, and preparation method of protein complexes |
02/05/2014 | CN103554143A Derivatives of 1-amino-2-cyclobutylethylboronic acid |
02/05/2014 | CN103554140A Preparation method and application of anthraquinone polypyridine ligand and binuclear ruthenium complexes |
02/05/2014 | CN103554137A Preparation method of cefdinir micropowder |
02/05/2014 | CN103554134A Chromone structure containing isoxazole norcantharidin derivatives as well as preparation method and application thereof |
02/05/2014 | CN103554132A Tetrahydrothieno-[2,3-c]pyridine deuterated derivatives and preparation method and medicament applications thereof |
02/05/2014 | CN103554116A Molecularly targeted anti-cancer photosensitizer tamoxifen-phthalocyanine conjugate and preparation method thereof |
02/05/2014 | CN103554107A Azaadamantane derivatives and methods of use |
02/05/2014 | CN103554104A Azaindoles useful as inhibitors of jak and other protein kinases |
02/05/2014 | CN103554103A Indole[3,2-c]quinoline compounds or pharmaceutically acceptable salts thereof, and preparation method and application thereof |
02/05/2014 | CN103554101A 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha7-nachr ligands for the treatment of cns diseases |
02/05/2014 | CN103554095A Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
02/05/2014 | CN103554091A Quinazoline derivative as well as preparation method and use thereof |
02/05/2014 | CN103554088A Benzodiazepine compound and pharmaceutical composition |
02/05/2014 | CN103554086A Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
02/05/2014 | CN103554070A Ascorbic acid bismuth oxide, preparation method and application of ascorbic acid bismuth oxide |
02/05/2014 | CN103554046A Chicken coccidiosis preventing triazine compound |
02/05/2014 | CN103554042A Triazole compounds that modulate hsp90 activity |
02/05/2014 | CN103554038A Polyhalogenated benzonitrile quinazolone compounds, preparation method and use thereof |
02/05/2014 | CN103554030A Novel forms of bendamustine free base |
02/05/2014 | CN103554025A 3-pyrazole carboxylic acid amide compound and preparation method thereof as well as application of compound in preparation of medicaments as CB1 receptor inhibitors |
02/05/2014 | CN103554021A Indanone tetrahydroisoquinoline derivative as well as preparation method and medical application thereof |
02/05/2014 | CN103554008A 1,3-substituted-5-acetaminoindolone compounds and application thereof to anti-tumor drugs |
02/05/2014 | CN103554006A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
02/05/2014 | CN103554004A Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
02/05/2014 | CN103554000A (S)-oxiracetam crystal form III, and preparation method and application thereof |
02/05/2014 | CN103553996A Anticholinergic pharmaceutical composition |
02/05/2014 | CN103553973A o-nitroaroyl beta-chloroethyl nitrosourea compounds, preparation and use thereof |
02/05/2014 | CN103553966A Solid forms of selective androgen receptor modulators |
02/05/2014 | CN103553957A Colchicine derivative containing histone deacetylase inhibitory activity, preparation method and application thereof |